A bill sponsored by Utah Senator Orrin Hatch that will require manufacturers of dietary supplements to report adverse reactions to their products has cleared the House and Senate and now awaits President Bush's signature.
Wyeth is facing lawsuits filed by five women who claim the drug maker's Pondimin and Redux in a fen-phen diet drug combination caused a serious lung disease years after they stopped taking the drugs.
Chief U.S. District Judge Garrett Brown in Trenton, New Jersey, on Nov. 3 approved diet drug maker Nutraquest's bid to emerge from Chapter 11 bankruptcy protection forced three years earlier by multiple ephedra-related lawsuits.
The Nutraceutical Corporation has requested a rehearing before the entire 19-member 10th U.S. Circuit Court of Appeals in Denver in an effort to have the FDA ban on the controversial diet supplement ephedra eased.
The various parties involved in the bankruptcy proceedings of diet-drug maker Metabolife International agreed September 26 to settle most of the personal injury lawsuits tied to the company's ephedra-containing diet supplement for $56 million.
Two judges, one in San Diego and one in New York, have threatened court action to end ongoing squabbling by the various parties involved in the bankruptcy proceedings of the now-defunct diet-drug maker Metabolife.
The U.S. Food and Drug Administration's ban on ephedra was upheld August 18 when a federal appeals court in Denver ruled that the FDA had correctly adhered to a congressional mandate in determining that ephedra is unsafe.
New York law firm Parker & Waichman won a rare appeals court reversal relating to a decision that overturned a ruling in a fen-phen-connected suit Parker had brought against the law firm Napoli Kaiser & Bern LLP.
Nutraquest Inc. agreed June 15 to settle for $1 million a suit brought by California prosecutors accusing the diet-pill maker of deceptive practices in marketing its ephedra-containing products.
Pharmaceutical company Wyeth will pay hundreds of millions of dollars to settle thousands of fen-phen-related suits brought by Texas residents who took the company's diet drugs Pondimin and Redux.
Ex–dietary supplement maker Metabolife International Inc. is asking the bankruptcy court to approve a $4.7 million settlement to close 21 personal injury lawsuits totaling $130.4 million filed because of health problems caused by its ephedra-containing supplement Metabolife 356.
FDA attorney Christine Kohl argued May 8 in Denver's 10th U.S. Circuit Court of Appeals for the reversal of a Utah judge's ruling that allowed the sale of ephedra in doses up to 10 milligrams.
Emax Enterprises has filed suit demanding return of a shipment of confiscated ephedra products. Meantime, the FDA will argue May 8 in a Denver appeals court for reversal of a pro-ephedra ruling.
LEXINGTON, Ky. - Attorneys William Gallion, Shirley Cunningham, and Melbourne Mills Jr., accused by their former clients of pocketing excessive fees from the settlement of a fen phen case, say that they paid themselves more than $20 million each on a court order from former Circuit Court Judge Joseph Bamberger.
The U.S. Food and Drug Administration (FDA) has been petitioned to remove the prescription diet drug Xenical (orlistat) from the market. Public Citizen, a consumer watchdog group, filed the petition.
Last Friday, a doctor from Keithville, La. pleaded guilty in federal court to illegally selling prescription drugs via the Internet.
A judge from Northern Kentucky who recently resigned after allegedly profiting from a $200 million Fen-Phen settlement will have his retirement pay cut.
On Wednesday, representatives from Wyeth said that a Texas jury ruled in its favor in a fen-phen lawsuit.
A judge serving in northern Kentucky resigned earlier this week after he was publicly reprimanded for profiting from a $200 million Fen-Phen settlement.
On Friday, pharmaceutical company Wyeth announced that a Philadelphia jury ruled in its favor in a fen-phen product liability case. The same jury awarded modest damages to a plaintiff in another case.
Two years after filing Chapter 11 bankruptcy protection, Nutraquest and dozens of other companies have agreed on a multimillion dollar settlement of injury claims related to the use of ephedra.
A recent Anderson County fen-phen case that ended in a mistrial on February 2 has now been reset for June.
A fen-phen lawsuit involving a Southeast Texas woman settled in a Jefferson County court for a confidential, undisclosed amount.
The Anderson County trial against Wyeth, the pharmaceutical company that marketed the diet drug fen-phen, was declared a mistrial on Tuesday. This is just one day after the trial began.
Despite the Food and Drug Administration's ban on products containing ephedra in 2004, a few products containing the weight loss additive are back on the market.
The jury in the Philadelphia Court of Common Pleas found in favor of drug company Wyeth in three different cases today. The plaintiffs in the case alleged Wyeth diet drug Pondimin caused heart valve damage.
Some varieties of Brazilian diet pills, a popular over-the-counter diet drug system, have been found to contain dangerous controlled substances.
Research performed at the University of California, San Francisco discovered that two ephedra-free diet supplements, Advantra Z and Xenadrine EFX, posed health risks similar to ephedra-based supplements.
California governor Arnold Schwarzenegger singed a bill on Friday that prohibits high school athletes from using the nutritional supplements ephedra, synephrine and DHEA.
Metabolife International Inc., a San Diego-based retailer of several weight loss supplements containing the banned herb ephedra, pleaded guilty on Wednesday to falsifying tax returns. The company will be sentenced in December.
Two former owners of a weight-loss clinic admitted to a U.S. District Court in Kansas City that they had illegally imported some 22 pounds of fenfluramine, a substance used in the diet drug Fen-Phen.
Budget Pharmacy, a drug store located in Lower Southampton, Pennsylvania, has come under federal scrutiny for illegally selling $13.1 million in prescription diet drugs over the Internet.
The Food and Drug Administration (FDA) announced that it will not impose a ban on Meridia. The FDA will, however, monitor a European study that is observing the drug's health risks.
A judge in Cook County approved a $16 million settlement against Northwestern University for the wrongful death of Rashidi Wheeler. Northwestern officials contend Ephedra supplements led to Wheeler's death, though Wheeler's mother, Linda Will, still holds the athletic department responsible.
A study in the July issue of Medicine finds that herbal remedies kava (used to relieve anxiety) and valerian (used to treat insomnia) are no more effective than placebos.
Fayette, Mississippi resident Zandra Gray pled guilty to wire fraud on Friday in the federal Fen-Phen settlement investigation. Gray will be sentenced on Sept. 23 and faces up to 20 years in prison.
A study published in the June 2005 issue of Clinical Pharmacology and Therapeutics stated that weight loss supplements containing ephedra and guarana may be harmful to obese people who suffer from clogged arteries, glucose intolerance, or high blood pressure.
Nutraquest, makers of an ephedra based weight loss product, will pay nearly one million dollars to settle claims of false advertising.
©2008 Einstein Law All Rights Reserved